Press release
Animal Biotechnology Market to Reach USD 49.02 Billion by 2030, Growing at 9.9% CAGR
Animal Biotechnology Market
The growing incidence of conditions such as cancer, avian influenza, and foot-and-mouth disease has intensified the need for robust diagnostic, preventive, and therapeutic solutions. North America led the global market in 2024 owing to mature R&D infrastructure, while China is forecast to register the fastest CAGR from 2025 to 2030, driven by biotech innovation and government support. The dominance of the biologics segment, which accounted for USD 9.73 billion in 2024, reflects the market's shift toward preventive healthcare and advanced biologic therapies that enhance animal immunity and productivity.
Get a Free Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.datamintelligence.com/download-sample/animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar
Key Highlights from the Report
➤ Global animal biotechnology market to reach USD 49.02 billion by 2030 at a 9.9% CAGR.
➤ Biologics led the market with USD 9.73 billion in 2024 and remain the fastest-growing segment.
➤ North America dominated with a 34% revenue share in 2024, driven by high veterinary R&D investment.
➤ China projected to exhibit the highest growth rate over the forecast period.
➤ Laboratories held 35.24% market share, underscoring their leading role in diagnostics and R&D research.
➤ Rapid innovation in vaccines, stem-cell therapies, and monoclonal antibodies drives industry adoption.
Market Segmentation
The biologics segment accounted for the largest share of over 31.5% in 2024, supported by rising use of vaccines, mAbs, and gene-based therapies for preventive and therapeutic applications. For instance, Yale University's 2024 canine cancer vaccine improved tumor response and increased survival rates by 25 percentage points compared to traditional treatments. Similarly, Washington State University's Feed the Future Veterinary Vaccine Lab launched in Africa aims to expand vaccine coverage in livestock populations.
By application, the preventive care category dominated in 2024, driven by the pet humanization trend and expanding veterinary vaccinations. Governments and private organizations are promoting animal care initiatives that emphasize regular preventive health programs for pets and livestock. Moreover, the product R&D segment is growing rapidly, fueled by active investments from universities and biotech firms focused on genetic research and advanced diagnostics such as UC Davis's Veterinary Genetics Laboratory expansion initiative.
In terms of animal type, livestock led the market due to the growing demand for safe and sustainable animal-derived food products, while companion animals are expected to experience the highest growth rate, influenced by innovations in pain management, stem-cell therapy, and personalized nutrition.
Get Customization in the Report as Per Your Business Requirements: https://www.datamintelligence.com/customize/animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar
Regional Insights
North America held the largest market share, exceeding 34% in 2024, underpinned by strong veterinary infrastructure, R&D initiatives, and corporate expansions. For instance, Elanco Animal Health invested USD 130 million in expanding its Kansas-based facility to strengthen biologics manufacturing capabilities. Regulatory advancements, such as the U.S. FDA's framework updates for heritable genomic alterations in animals, further support innovation and product approvals.
Europe is witnessing rapid growth through consolidation and R&D collaborations. Companies like Ceva Santé Animale and Dechra Pharmaceuticals have prioritized acquisitions-such as Ceva's acquisition of Scout Bio-to enhance capabilities in monoclonal antibodies and gene therapies. UK-based collaborations continue to strengthen biotherapeutic development for chronic veterinary diseases.
Asia Pacific is projected to record the highest CAGR, led by China, India, and Japan. Factors such as a growing pet population, government biotech initiatives, and increased protein consumption are accelerating market expansion. For example, China's Ringbio launched an advanced ELISA kit targeting Brucella infections, while India's NIAB-Pirbright collaboration strengthened zoonotic research and local vaccine production.
In Latin America, nations like Brazil and Argentina are fostering innovations through public-private collaborations, such as Biogénesis Bagó's USD 30 million vaccine facility expansion, while in the Middle East and Africa (MEA), Israel's Remilk and South Africa's Afrigen Biologics are pioneering cost-effective biotech and mAb solutions using novel production techniques like transgenic goat milk.
Market Dynamics
Market Drivers
Rising investments in veterinary biotechnology, a surge in companion animal adoption, and global efforts to combat animal-borne diseases drive demand for biologics, diagnostics, and genetic innovations. Increasing focus on food security and zoonotic disease prevention further enhances biotechnology adoption across livestock and companion animal sectors.
Market Restraints
High development costs, long regulatory approval cycles, and limited access to advanced laboratory infrastructure in developing regions constrain market growth. Additionally, a shortage of skilled professionals in veterinary biotechnology continues to challenge full-scale commercialization.
Market Opportunities
Rising demand for next-generation vaccines, gene-editing tools, and cell therapies presents significant opportunities. Collaborative R&D initiatives and global alliances are fostering faster drug approvals. Government-backed initiatives, such as GMP standardization for veterinary APIs, provide long-term growth potential by regulating safety, efficacy, and manufacturing consistency.
Purchase This Exclusive Report at Just USD 5368 Only: https://www.datamintelligence.com/buy-now-page?report=animal-biotechnology-market?utm_source=OpenPR&utm_campaign=Onkar
Reasons to Buy the Report
✔ Comprehensive analysis of key trends shaping global animal biotechnology innovation.
✔ Insight into regional market dynamics and emerging opportunities.
✔ Strategic breakdown of biologics, diagnostics, and R&D application segments.
✔ Evaluation of competitive strategies among leading biotechnology firms.
✔ Identification of high-growth regions and future investment hotspots.
Frequently Asked Questions (FAQs)
◆ How big is the global animal biotechnology market in 2024?
◆ What is the projected CAGR for the animal biotechnology market through 2030?
◆ Which segment dominates the global animal biotechnology industry?
◆ Which region will record the fastest growth in the animal biotechnology market?
◆ Who are the key players shaping the global animal biotechnology landscape?
Company Insights
Zoetis
Boehringer Ingelheim
Merck & Co., Inc.
Virbac
Elanco Animal Health
IDEXX Laboratories
Dechra Pharmaceuticals
Heska Corporation
Indian Immunologicals Ltd
Hester Biosciences Pvt. Ltd
Biogénesis Bagó
Recent Developments
In September 2024, Zoetis expanded its Hyderabad vaccine manufacturing facility to increase production of advanced biologics and diagnostic tools for livestock and pet health.
In August 2024, Anvive Lifescience Inc. secured a USD 33 million contract with the U.S. NIH to develop a vaccine for Valley Fever in dogs, highlighting ongoing innovation in zoonotic disease prevention.
In September 2024, Bioassay GmbH obtained GMP certification for its veterinary bioanalytical testing plant in Germany, reinforcing compliance with new manufacturing quality standards.
Conclusion
The global animal biotechnology market is poised for transformative growth, backed by scientific innovation, increasing global disease outbreaks, and expanding collaborations across borders. With a potential market valuation of USD 49.02 billion by 2030, the sector's trajectory is defined by its pivotal role in ensuring animal health, sustainable agriculture, and biosecurity. The dominance of biologics, ongoing advancements in genetic engineering, and the rise of veterinary startups are reshaping the future of animal biotechnology worldwide.
Contact Us
Mr. Sai Kiran
DataM Intelligence 4market Research LLP Ground floor
DSL Abacus IT Park, Industrial Development Area
Uppal, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com
Visit Our Website: https://www.datamintelligence.com
About Us
DataM Intelligence 4Market Research is a comprehensive market intelligence platform offering syndicated and customized reports along with expert consulting across multiple industries, including chemicals, healthcare, agriculture, food & beverages, and more. With extensive experience and a strategy-focused approach, DataM provides businesses and individuals with reliable market insights, statistical forecasts, and personalized research solutions to help them make informed decisions and successfully bring innovations to market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Animal Biotechnology Market to Reach USD 49.02 Billion by 2030, Growing at 9.9% CAGR here
News-ID: 4237271 • Views: …
More Releases from DataM Intelligence
U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6 …
The United States radiopharmaceuticals market was valued at USD 2.21 billion in 2024 and is projected to reach USD 2.36 billion by 2033, exhibiting a CAGR of 6.3% during the forecast period, according to DataM Intelligence. The market expansion is primarily fueled by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, advancements in diagnostic imaging, and regulatory support for nuclear medicine infrastructure. Radiopharmaceuticals play a pivotal…
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR …
The U.S. flavors market was valued at USD 3,887.7 million in 2024 and is projected to reach USD 6,108.4 million by 2033, growing at a CAGR of 5.2% during 2025-2033, according to DataM Intelligence. The market's growth is driven by surging demand for processed foods, global flavor innovation, and increasing consumer preference for natural, clean-label, and wellness-oriented products. Flavors continue to play a vital role in enhancing the sensory experience…
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% …
The Europe Feed Premix Market is estimated to grow from USD 5.92 billion in 2025 to USD 7.31 billion by 2030, registering a CAGR of 4.32% during the forecast period, according to DataM Intelligence. The market's growth is driven by increasing demand for nutrient-rich animal feed formulations, expanding livestock production, and a rising preference for high-quality, antibiotic-free animal products. Feed premixes-comprising essential vitamins, minerals, amino acids, and other additives-are vital…
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growin …
The North America Feed Phytogenics Market is projected to grow from USD 383.10 million in 2025 to USD 500.60 million by 2030, at a CAGR of 5.5% during the forecast period, according to DataM Intelligence. The market is witnessing robust growth due to rising demand for high-quality animal-derived products and increasing regulatory restrictions on antibiotics in livestock production. As a result, plant-based feed solutions have gained widespread adoption for improving…
More Releases for USD
Bone Cement Market Outlook USD 1,871.10M-USD 3,512.31M
How Is the Bone Cement Market Supporting the Rise of Modern Orthopedic Surgery?
The Bone Cement Market plays a critical role in modern orthopedic and spinal procedures, acting as a foundational material for joint replacement, fracture fixation, and vertebral stabilization. Bone cement is widely used to anchor implants, restore bone structure, and improve patient mobility-making it an essential component of musculoskeletal care.
In 2025, the global bone cement market was valued at…
Autologous Cell Therapy Market Outlook USD 9.31B-USD 54.83B
How Is the Autologous Cell Therapy Market Redefining the Future of Precision Medicine?
The Autologous Cell Therapy Market is rapidly emerging as one of the most transformative areas in modern healthcare, offering highly personalized treatment options for complex and chronic diseases. By using a patient's own cells to repair, replace, or regenerate damaged tissues, autologous cell therapy minimizes immune rejection risks while maximizing therapeutic effectiveness.
In 2025, the global autologous cell therapy…
PACS Market USD 5.59B in 2025, USD 9.73B by 2035
Picture Archiving and Communication System (PACS) Market Expands as Digital Imaging Transforms Global Healthcare
Introduction: PACS at the Core of Modern Medical Imaging
The healthcare industry is undergoing a rapid digital transformation, with medical imaging playing a critical role in diagnosis, treatment planning, and patient monitoring. At the heart of this transformation lies the Picture Archiving and Communication System (PACS)-a technology that enables the storage, retrieval, management, and sharing of medical images…
Global HEOR Market USD 1.70B-USD 6.03B
Health Economics and Outcomes Research (HEOR) Market Accelerates as Value-Based Healthcare Redefines Global Decision-Making
Introduction: The Growing Importance of HEOR in Modern Healthcare
The global healthcare industry is undergoing a profound transformation, shifting from volume-driven care models to value-based healthcare systems that prioritize patient outcomes, cost efficiency, and real-world effectiveness. At the center of this transformation lies Health Economics and Outcomes Research (HEOR)-a discipline that evaluates the economic value, clinical outcomes, and…
Foam Tape Market Outlook 2035: Industry Growth from USD USD 4.89 Billion (2025) …
The Foam Tape Market plays a vital role in modern industrial and manufacturing ecosystems. Foam tapes are pressure-sensitive adhesive products manufactured using materials such as polyurethane, polyethylene, PVC, and acrylic foam. These tapes are widely used for bonding, sealing, insulation, cushioning, vibration damping, and noise reduction across multiple industries. Their ability to replace traditional mechanical fasteners like screws, bolts, and rivets has positioned foam tapes as a preferred solution in…
Chlorella Market Reach USD 465.85 Million USD by 2030
Market Growth Fueled by Increased Adoption of Plant-Based Proteins and Health Supplements
Global Chlorella Market size was valued at USD 303.75 Mn. in 2023 and the total Chlorella revenue is expected to grow by 6.3 % from 2024 to 2030, reaching nearly USD 465.85 Mn. . The growth of the market is majorly due to increase in the consumer awareness about health, the inclination towards plant-based food such as chlorella and…
